Adverse reactions to tocolytics

Atosiban v nifedipine

BMJ 2009; 338 doi: 10.1136/bmj.b1501 (Published 14 April 2009)
Cite this as: BMJ 2009;338:b1501

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Yves Jacquemyn, head1
  1. 1Department of Obstetrics and Gynaecology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium
  1. yves.jacquemyn{at}uza.be

    De Heus and colleagues conclude that oxytocin antagonists and calcium channel blockers should be compared for tocolytic efficiency and side effects. …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL